Jason Springs is currently the CEO of GeneWeave Biosciences, LLC. His company develops diagnostic devices that detect the presence and drug-resistance of disease-causing bacteria without the need for a diagnostic laboratory. The company is particularly focused on detecting so-called "superbugs" -disease-causing bacteria that are resistant or immune to standard antibiotics, as well as bacteria responsible for many hospital-acquired infections (HAIs).
Jason Springs is a first year MBA student at the Johnson School at Cornell University. He received his undergraduate degree in Economics and Management from the University of South Carolina.
So just like the standard business plan you got to convey the benefit to the customer a lot. A lot of people make the mistake of just kind of writing a technology overview and then somehow it's sold. The best parts of the business plan are why does our device work, why is it better than what else ...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login